BerandaBNTC • NASDAQ
add
Benitec Biopharma Inc
Tutup sebelumnya
$13,90
Rentang hari
$13,40 - $13,81
Rentang tahun
$5,74 - $16,90
Kapitalisasi pasar
347,05Â jt USD
Volume Rata-Rata
58,98Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 8,61Â jt | 24,31% |
Laba bersih | -7,36Â jt | -8,22% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -8,60Â jt | -24,40% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 78,28Â jt | 284,23% |
Total aset | 79,07Â jt | 270,29% |
Total liabilitas | 3,13Â jt | -46,85% |
Total ekuitas | 75,94 jt | — |
Saham yang beredar | 23,45 jt | — |
Harga terhadap nilai buku | 4,29 | — |
Tingkat pengembalian aset | -29,12% | — |
Tingkat pengembalian modal | -30,65% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -7,36Â jt | -8,22% |
Kas dari operasi | -7,70Â jt | -43,58% |
Kas dari investasi | -12,00 rb | — |
Kas dari pembiayaan | 17,87Â jt | 45.725,64% |
Perubahan kas bersih | 10,44Â jt | 290,20% |
Arus kas bebas | -5,70Â jt | -101,38% |
Tentang
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology.
The CSIRO has researched RNAi extensively, developing the small hairpin RNA concept employed in ddRNAi. Benitec Biopharma has an exclusive license to this ddRNAi technology in human therapeutic uses and research. Wikipedia
Didirikan
1997
Situs
Karyawan
16
